A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially deadly RSV.

Failure to recognize and resolve problems in an honest and evidence-based manner is the root cause of increasing vaccine ...

The FDA has approved clesrovimab -- sold as Enflonsia -- a new shot to prevent respiratory syncytial virus (RSV) infection in babies during their first RSV season, which typically lasts from fall ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

The CDC's newly reconstituted Advisory Committee on Immunization Practices (ACIP) voted 5-2 in support of infants younger ...

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine. What to know.

The Advisory Committee on Immunization Practices recommended clesrovimab for infants under eight months old born during or entering their first RSV season. Clesrovimab adds to existing RSV ...

The Advisory Committee on Immunization Practices recommended clesrovimab for infants under eight months old born during or entering their first RSV season. Clesrovimab adds to existing RSV ...